DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
18.17
-0.24 (-1.30%)
May 13, 2025, 1:44 PM CST
-17.86%
Market Cap 20.97B
Revenue (ttm) 26.70B
Net Income (ttm) 976.30M
Shares Out 1.14B
EPS (ttm) 0.86
PE Ratio 21.35
Forward PE 19.99
Dividend 0.62 (3.37%)
Ex-Dividend Date Oct 23, 2024
Volume 3,432,013
Average Volume 9,075,410
Open 18.37
Previous Close 18.41
Day's Range 18.09 - 18.43
52-Week Range 11.92 - 23.26
Beta 0.61
RSI 60.78
Earnings Date Apr 29, 2025

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 45,466
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2024, SHA:603233's revenue was 26.50 billion, an increase of 8.01% compared to the previous year's 24.53 billion. Earnings were 914.75 million, a decrease of -21.58%.

Financial Statements

News

There is no news available yet.